Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See Calendar
Close

Asymchem Laboratories Tian Jin Co Ltd (002821)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
117.96 +3.48    +3.04%
07:57:00 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE100002BZ6 
  • Volume: 10,271,272
  • Bid/Ask: 118.02 / 118.02
  • Day's Range: 112.88 - 118.30
Asymchem Laboratories Tian Jin 117.96 +3.48 +3.04%

Asymchem Laboratories Tian Jin Co Ltd Company Profile

 
Get an in-depth profile of Asymchem Laboratories Tian Jin Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

9788

Equity Type

ORD

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions. In addition, the company is involved in development and drug product manufacturing; provision of pharmaceutical analysis and testing services; medical research and development; manufacturing, sale, and development of medicine raw materials and relevant products; sale of drug products; pharmaceuticals and chemical manufacturing; wholesaling and retailing of drugs; sale, import and export trade; information technology; technology development; and research and experimental development activities. The company was founded in 1998 and is headquartered in Tianjin, China.

Contact Information

Address No. 6 Dongting 3rd Street Economic-Technological Development Area
Tianjin, 300457
China
Phone -
Fax -

Top Executives

Name Age Since Title
Hao Hong 69 2011 Founder, Chairman & CEO
Rui Yang 47 2011 Co-CEO & Executive Director
Stephen L. Buchwald - - Member of Scientific Advisory Board
Seble Wagaw - - Member of Scientific Advisory Board
Kar Chung Lee 43 2021 Independent Non Executive Director
Phil S. Baran 48 - Member of Scientific Advisory Board
Ye Song 64 2011 Non-Executive Director
Shanshan Di 38 2017 Shareholder representative Supervisor
Xinxin Zhi 44 2011 Chairman of the Supervisory Committee
Ting Zhang 39 2021 Non-Executive Director
Da Zhang 43 2018 CFO, COO, Senior VP & Executive Director
Patricia Alred - - Member of Scientific Advisory Board
Nicholas Turner - - Member of Scientific Advisory Board
Martin Eastgate - - Member of Scientific Advisory Board
Jin-Quan Yu - - Member of Scientific Advisory Board
Xuejiao Sun 42 2023 Independent Non-Executive Director
Xinyi Hou 64 2024 Independent Non-Executive Director
Timothy F. Jamison - - Member of Scientific Advisory Board
Stephane Caron - - Member of Scientific Advisory Board
Scott May - - Member of Scientific Advisory Board
Jingyi Hou 41 2021 Employee Representative Supervisor
Liang Hong 51 2011 Executive VP & Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

002821 Comments

Write your thoughts about Asymchem Laboratories Tian Jin Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email